Bortezomib (Velcade)
Drug timelines are a Plus or Pro feature.
34 regulatory and trial events tracked for Bortezomib (Velcade), covering 2010-07-28 to 2026-04-24. Get the full timeline:
Most recent: Clinical Trial Update: Trial of Duvelisib in Combination With Either Romidepsin or Bortezomib in Relapsed/Refractory T-cell Lymphomas [Phase 1]